Reduce peripheral vascular resistance, increase cardiac output, reduce venous pressure, activate fibrinolysis, reduce fibrinogen levels, prevent platelet aggregation, promote the synthesis of pyrimidine nucleosides (NAD and NADP), increase the concentration of adenine nucleosides (AMP, ADP and ATP), hinder lipolysis, and reduce elevated cholesterol and triglyceride levels

The antibacterial spectrum is similar to that of rifampicin. It has good antibacterial activity against tuberculosis and leprosy. When the dosage is 1/3 of that of rifampicin, similar or higher efficacy can be achieved. It has a good effect on Staphylococcus aureus and has certain antibacterial activity against some Escherichia coli. In addition, it also has an inhibitory effect on Chlamydia trachomatis.

Aminoglycoside antibiotics have antibacterial effects on most Enterobacteriaceae, influenza bacilli, Brucella, meningococci, gonococci, Staphylococci (methicillin-sensitive strains) and Mycobacterium tuberculosis, and may have partial or complete cross-resistance with other aminoglycosides. They inhibit bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes.

Broad-spectrum antiviral drugs, composed of multi-molecule nucleotides, can induce interferon in the body and have good therapeutic effects on diseases caused by various viruses. They also promote antibody formation and stimulate macrophage phagocytosis.

It is a vasodilator that can dilate coronary arteries and cerebral blood vessels, reduce myocardial oxygen consumption, improve microcirculation and resist platelet aggregation. Animal experiments have shown that: 1. The various total flavonoid compounds in Pueraria root can relax smooth muscles, while the contractile components may be substances such as choline, acetylcholine and carbazine R; 2. Pueraria root has a certain antihypertensive effect on normal and hypertensive animals; 3. Pueraria root total flavonoids and puerarin have a significant dilating effect on coronary arteries, which can dilate normal and spasmodic coronary arteries. After intravenous injection, coronary blood flow can increase by 40% and vascular resistance can be reduced by 29%; 4. Puerarin can also inhibit the release of 5-HT in platelets induced by thrombin.